MxD has been awarded $15 million in funding from the U.S. Department of Defense via the Coronavirus Aid, Relief, and Economic Security (CARES) Act to address critical public health and infrastructure needs and to support manufacturing as it mobilizes in response to COVID-19.
MxD’s three CARES Act-funded programs will focus on supply chain resiliency and transparency, rapid and secure medical device deployment, and pharmaceutical industry production optimization.
Even before the pandemic temporarily closed factories and exposed supply chain shortcomings, American manufacturers were experiencing rapid change on all fronts: ecosystems, business models, technology, customer expectations, and workforce. Companies, some of them more than a century old, have been under pressure for years to transform and become more resilient – or face extinction. Newer entrants have used digital technology to become more agile and leap-frog competitors.
And in the current environment, all of manufacturing has come to grips with the fact that better planning is needed for future crises.